Abbas, Qasir
Nisa, Mehru
Khan, Muhammad Umar
Anwar, Nida
Aljhani, Sumayah
Ramzan, Zoobia
Shahzadi, Mafia
Article History
Received: 10 April 2023
Accepted: 7 July 2023
First Online: 25 July 2023
Declarations
:
: Ethical approval was taken from the Institutional Review Board (IRB), Government College University, Faisalabad, Pakistan (i.e. Ref.No. GCUF/ERC/2267, dated 17/06/2021), and then the protocol was approved by the Thai clinical trial registry (i.e. TCTR = TCTR20210702002, with URL: ExternalRef removed), with first registration date 02/07/2021. Participants gave written informed consent before the process of enrollment and screening. All procedures were performed under relevant guidelines, including participant enrollment, screening, data collection, data scrutiny, and analysis. We followed the Consolidated Standards of Reporting Trials CONSORT reporting guidelines. Furthermore, we confirm that all of the procedure and methods of this study were executed by adhering to the requirements of our institutional review board, and the global code of conduct for research in resource-poor settings.
: Not applicable.
: The authors declare no competing interests.